Home / MBXBF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MBXBF make money? Does MBXBF have pricing power? What's the Earnings Whisper? Will MBXBF profit more as the business scales? What is MBXBF's management track record? Is MBXBF's current price justified?

Microbix Biosystems Inc.

$0.22 +$0.04 (+23.51%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.21

Day Range

$0.22 - $0.22

Year Range

$0.15$0.23

Market Cap

29.84M

AVG Volume

8.64K

Trailing/Forward PE

-8.78/21.53

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-12-17

Primary Exchange

Other OTC

Revenue (CAD)

MBXBF Revenue (CAD) by quarter
Period	Revenue (CAD)
26 Q3	4.06M
26 Q2	3.39M
26 Q1	4.22M
25 Q4	3.75M
25 Q3	3.47M
25 Q2	5.32M
25 Q1	6.04M
24 Q4	6.29M
24 Q3	5.06M
24 Q2	5.63M

Net Income (CAD)

MBXBF Net Income (CAD) by quarter
Period	Net Income (CAD)
26 Q3	-807.11K
26 Q2	-1.43M
26 Q1	-1.17M
25 Q4	-1M
25 Q3	-1.64M
25 Q2	20.66K
25 Q1	856.96K
24 Q4	440.32K
24 Q3	246.75K
24 Q2	377.73K

Operating Income (CAD)

MBXBF Operating Income (CAD) by quarter
Period	Operating Income (CAD)
26 Q3	-658.47K
26 Q2	-1.27M
26 Q1	-948.42K
25 Q4	-1.52M
25 Q3	-1.33M
25 Q2	178.62K
25 Q1	970.09K
24 Q4	710.78K
24 Q3	165.31K
24 Q2	459.06K

EBITDA (CAD)

MBXBF EBITDA (CAD) by quarter
Period	EBITDA (CAD)
26 Q3	-186.53K
26 Q2	-800.91K
26 Q1	-492.5K
25 Q4	-1M
25 Q3	-972.81K
25 Q2	699.93K
25 Q1	1.52M
24 Q4	1.22M
24 Q3	904.17K
24 Q2	1.01M

Cash Flows (CAD)

MBXBF Cash Flows (CAD) by quarter
Period	Cash Flows (CAD)
26 Q3	-514.9K
26 Q2	-531.77K
26 Q1	-2.77M
25 Q4	-70.45K
25 Q3	-2.12M
25 Q2	721.46K
25 Q1	589.65K
24 Q4	536.44K
24 Q3	400.84K
24 Q2	201.34K

EPS (CAD)

MBXBF EPS (CAD) by quarter
Period	EPS (CAD)
26 Q3	-0.01
26 Q2	-0.01
26 Q1	-0.01
25 Q4	-0.01
25 Q3	-0.01
25 Q2	0
25 Q1	0.01
24 Q4	0
24 Q3	0
24 Q2	0

Expenses (CAD)

MBXBF Expenses (CAD) by quarter
Period	Expenses (CAD)
26 Q3	2.9M
26 Q2	3.12M
26 Q1	2.85M
25 Q4	3.08M
25 Q3	2.94M
25 Q2	3.24M
25 Q1	2.99M
24 Q4	2.49M
24 Q3	3.59M
24 Q2	3.15M

Cash & Debt (CAD)

MBXBF Cash & Debt (CAD) by quarter
Period	Cash & Debt (CAD)
26 Q3	7.16M
26 Q2	8.15M
26 Q1	9.09M
25 Q4	12.13M
25 Q3	12.1M
25 Q2	14.54M
25 Q1	13.05M
24 Q4	12.96M
24 Q3	12.81M
24 Q2	12.87M

Debt ratios

MBXBF Debt ratios by quarter
Period	Debt ratios
26 Q3	0.18
26 Q2	0.41
26 Q1	0.56
25 Q4	-21.38
25 Q3	-2.31
25 Q2	-2.11
25 Q1	-1.42
24 Q4	-1.08
24 Q3	-1.61
24 Q2	-2.16

Margins

MBXBF Margins by quarter
Period	Margins
26 Q3	53.92%
26 Q2	48.2%
26 Q1	41.09%
25 Q4	40.47%
25 Q3	40.75%
25 Q2	59.5%
25 Q1	62.09%
24 Q4	54.82%
24 Q3	54.32%
24 Q2	52.74%

Return on Capital

MBXBF Return on Capital by quarter
Period	Return on Capital
26 Q3	-3.33%
26 Q2	-5.69%
26 Q1	-4.39%
25 Q4	-3.59%
25 Q3	-5.6%
25 Q2	0.07%
25 Q1	2.97%
24 Q4	1.56%
24 Q3	0.88%
24 Q2	1.36%

Shares Outstanding

MBXBF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q3	137.57M
26 Q2	138.67M
26 Q1	139.05M
25 Q4	139.25M
25 Q3	140.58M
25 Q2	139.85M
25 Q1	134.91M
24 Q4	135.81M
24 Q3	136.84M
24 Q2	137.37M

Book Value Per Share (CAD)

MBXBF Book Value Per Share (CAD) by quarter
Period	Book Value Per Share (CAD)
26 Q3	0.18
26 Q2	0.18
26 Q1	0.19
25 Q4	0.2
25 Q3	0.21
25 Q2	0.22
25 Q1	0.21
24 Q4	0.21
24 Q3	0.2
24 Q2	0.2

Total Assets (CAD)

MBXBF Total Assets (CAD) by quarter
Period	Total Assets (CAD)
26 Q3	34.07M
26 Q2	35.46M
26 Q1	36.56M
25 Q4	37.46M
25 Q3	38.26M
25 Q2	39.37M
25 Q1	39.3M
24 Q4	38.1M
24 Q3	37.73M
24 Q2	37.92M

PE Ratio

MBXBF PE Ratio by quarter
Period	PE Ratio
Sep 25	24.04
Sep 25	21.66
Sep 25	20.63
Sep 25	20.39
Aug 25	21.16
Aug 25	20.75
Aug 25	22.22
Aug 25	25.81
Aug 25	26.37
Jul 25	26.2
Jul 25	26.85
Jul 25	26.42
Jul 25	26.58
Jun 25	20.99
Jun 25	21.5
Jun 25	21.56
Jun 25	23.06
May 25	23.14
May 25	24.34
May 25	24.51
May 25	24.94
May 25	26.18
Apr 25	23.82
Apr 25	25.67
Apr 25	24.82
Apr 25	29.86
Mar 25	16.24
Mar 25	15.5
Mar 25	15.35
Mar 25	14.79
Feb 25	16.97
Feb 25	19.01
Feb 25	20.79
Feb 25	18.9
Jan 25	18.71
Jan 25	18.85
Jan 25	16.87
Jan 25	16.56
Jan 25	16.16
Dec 24	10.91
Dec 24	10.65
Dec 24	9.2
Dec 24	9.38
Nov 24	8.38
Nov 24	8.1
Nov 24	8.31
Nov 24	8.58
Nov 24	8.34
Oct 24	9.09
Oct 24	9.15
Oct 24	9.33
Oct 24	9.88
Sep 24	11.56
Sep 24	11.61
Sep 24	11.9
Sep 24	13.08
Aug 24	12.95
Aug 24	12.24
Aug 24	11.7
Aug 24	10.03
Aug 24	10.13
Jul 24	10.11
Jul 24	10.91
Jul 24	10.27
Jul 24	10.15
Jun 24	11.82
Jun 24	15.04
Jun 24	12.92
Jun 24	13.29
May 24	12.88
May 24	12.6
May 24	13.51
Apr 24	13.02
Apr 24	13.86
Apr 24	14.53
Apr 24	14.67
Mar 23	36.78
Mar 23	36.37
Mar 23	33.97
Mar 23	33.69
Feb 23	38.47
Feb 23	39.57
Feb 23	30.2
Feb 23	37.35
Jan 23	38.28
Jan 23	38.75
Jan 23	38.88
Jan 23	39.62
Dec 22	39.99
Dec 22	20.99
Dec 22	22.31
Dec 22	23.08
Dec 22	22.78
Nov 22	24.36
Nov 22	25.08
Nov 22	25.33
Nov 22	25.96
Oct 22	25.35
Oct 22	25.71
Oct 22	24.78

Free Cash Flow Yield

MBXBF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-13.16%
Sep 26	-13.19%
Aug 26	-13.13%
Aug 26	-13.26%
Aug 26	-12.98%
Aug 26	-12.92%
Jul 26	-12.85%
Jul 26	-12.83%
Jul 26	-13.39%
Jul 26	-13.02%
Jul 26	-12.93%
Jun 26	-10.23%
Jun 26	-9.84%
Jun 26	-11.65%
Jun 26	-11.69%
May 26	-11.66%
May 26	-12.14%
May 26	-13.44%
May 26	-12.52%
May 26	-12.33%
Apr 26	-12.74%
Apr 26	-13.25%
Apr 26	-13.11%
Apr 26	-13.43%
Mar 26	-2.64%
Mar 26	-2.53%
Mar 26	-2.44%
Mar 26	-2.72%
Feb 26	-2.68%
Feb 26	-2.92%
Feb 26	-2.93%
Feb 26	-2.92%
Jan 26	-2.92%
Jan 26	-2.72%
Jan 26	-2.5%
Jan 26	-2.52%
Jan 26	-2.61%
Dec 25	-0.86%
Dec 25	-0.88%
Dec 25	-0.78%
Dec 25	-0.85%
Nov 25	-0.78%
Nov 25	-0.8%
Nov 25	-0.76%
Nov 25	-0.77%
Oct 25	-0.76%
Oct 25	-0.78%
Oct 25	-0.74%
Oct 25	-0.7%
Oct 25	-0.75%
Sep 25	5.98%
Sep 25	6.63%
Sep 25	6.97%
Sep 25	7.05%
Aug 25	6.79%
Aug 25	6.92%
Aug 25	6.47%
Aug 25	5.57%
Aug 25	5.45%
Jul 25	5.49%
Jul 25	5.35%
Jul 25	5.44%
Jul 25	5.41%
Jun 25	4.28%
Jun 25	4.18%
Jun 25	4.17%
Jun 25	3.9%
May 25	3.89%
May 25	3.69%
May 25	3.67%
May 25	3.61%
May 25	3.44%
Apr 25	3.78%
Apr 25	3.5%
Apr 25	3.62%
Apr 25	3.01%
Mar 25	4.27%
Mar 25	4.47%
Mar 25	4.52%
Mar 25	4.69%
Feb 25	4.09%
Feb 25	3.65%
Feb 25	3.34%
Feb 25	3.67%
Jan 25	3.71%
Jan 25	3.68%
Jan 25	4.11%
Jan 25	4.19%
Jan 25	4.29%
Dec 24	0.6%
Dec 24	0.61%
Dec 24	0.71%
Dec 24	0.69%
Nov 24	0.78%
Nov 24	0.8%
Nov 24	0.78%
Nov 24	0.76%
Nov 24	0.78%
Oct 24	0.72%
Oct 24	0.71%

Price to Sales

MBXBF Price to Sales by quarter
Period	Price to Sales
Sep 26	2.82
Sep 26	2.81
Aug 26	2.82
Aug 26	2.79
Aug 26	2.85
Aug 26	2.87
Jul 26	2.88
Jul 26	2.89
Jul 26	2.77
Jul 26	2.85
Jul 26	2.87
Jun 26	2.47
Jun 26	2.57
Jun 26	2.17
Jun 26	2.16
May 26	2.17
May 26	2.08
May 26	1.88
May 26	2.02
May 26	2.05
Apr 26	1.98
Apr 26	1.91
Apr 26	1.93
Apr 26	1.88
Mar 26	1.79
Mar 26	1.86
Mar 26	1.94
Mar 26	1.74
Feb 26	1.76
Feb 26	1.62
Feb 26	1.61
Feb 26	1.62
Jan 26	1.62
Jan 26	1.73
Jan 26	1.89
Jan 26	1.88
Jan 26	1.81
Dec 25	1.49
Dec 25	1.46
Dec 25	1.65
Dec 25	1.52
Nov 25	1.64
Nov 25	1.6
Nov 25	1.69
Nov 25	1.66
Oct 25	1.68
Oct 25	1.65
Oct 25	1.73
Oct 25	1.84
Oct 25	1.71
Sep 25	1.66
Sep 25	1.49
Sep 25	1.42
Sep 25	1.4
Aug 25	1.46
Aug 25	1.43
Aug 25	1.53
Aug 25	1.78
Aug 25	1.82
Jul 25	1.8
Jul 25	1.85
Jul 25	1.82
Jul 25	1.83
Jun 25	1.75
Jun 25	1.79
Jun 25	1.8
Jun 25	1.92
May 25	1.93
May 25	2.03
May 25	2.05
May 25	2.08
May 25	2.18
Apr 25	1.99
Apr 25	2.14
Apr 25	2.07
Apr 25	2.49
Mar 25	2.25
Mar 25	2.15
Mar 25	2.13
Mar 25	2.05
Feb 25	2.35
Feb 25	2.63
Feb 25	2.88
Feb 25	2.62
Jan 25	2.59
Jan 25	2.61
Jan 25	2.34
Jan 25	2.3
Jan 25	2.24
Dec 24	2.37
Dec 24	2.31
Dec 24	2
Dec 24	2.04
Nov 24	1.82
Nov 24	1.76
Nov 24	1.81
Nov 24	1.86
Nov 24	1.81
Oct 24	1.97
Oct 24	1.99

EV/EBITDA

MBXBF EV/EBITDA by quarter
Period	EV/EBITDA
Mar 26	111.65
Mar 26	117.18
Mar 26	122.53
Mar 26	107.72
Feb 26	109.39
Feb 26	98.91
Feb 26	98.39
Feb 26	98.88
Jan 26	98.68
Jan 26	107.43
Jan 26	118.84
Jan 26	118.03
Jan 26	112.92
Dec 25	10.46
Dec 25	10.18
Dec 25	11.8
Dec 25	10.67
Nov 25	11.69
Nov 25	11.42
Nov 25	12.17
Nov 25	11.87
Oct 25	12.04
Oct 25	11.79
Oct 25	12.54
Oct 25	13.42
Oct 25	12.34
Sep 25	6.54
Sep 25	5.68
Sep 25	5.31
Sep 25	5.22
Aug 25	5.5
Aug 25	5.36
Aug 25	5.89
Aug 25	7.18
Aug 25	7.38
Jul 25	7.32
Jul 25	7.55
Jul 25	7.4
Jul 25	7.46
Jun 25	7.24
Jun 25	7.45
Jun 25	7.47
Jun 25	8.09
May 25	8.12
May 25	8.62
May 25	8.69
May 25	8.86
May 25	9.38
Apr 25	8.4
Apr 25	9.17
Apr 25	8.81
Apr 25	10.89
Mar 25	8.31
Mar 25	7.88
Mar 25	7.8
Mar 25	7.47
Feb 25	8.73
Feb 25	9.91
Feb 25	10.94
Feb 25	9.84
Jan 25	9.74
Jan 25	9.82
Jan 25	8.67
Jan 25	8.49
Jan 25	8.26
Dec 24	12.22
Dec 24	11.89
Dec 24	10.05
Dec 24	10.28
Nov 24	9
Nov 24	8.65
Nov 24	8.92
Nov 24	9.26
Nov 24	8.96
Oct 24	9.91
Oct 24	9.98
Oct 24	10.21
Oct 24	10.91
Sep 24	14.29
Sep 24	14.36
Sep 24	14.77
Sep 24	16.45
Aug 24	16.27
Aug 24	15.26
Aug 24	14.49
Aug 24	12.11
Aug 24	12.26
Jul 24	12.22
Jul 24	13.37
Jul 24	12.46
Jul 24	12.28
Jun 24	14.92
Jun 24	19.67
Jun 24	16.54
Jun 24	17.09
May 24	16.48
May 24	16.06
May 24	17.41
Apr 24	16.68
Apr 24	17.93

Price/Operating Cashflow

MBXBF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Dec 25	52.38
Dec 25	51.25
Dec 25	57.91
Dec 25	53.26
Nov 25	57.45
Nov 25	56.32
Nov 25	59.41
Nov 25	58.17
Oct 25	58.88
Oct 25	57.87
Oct 25	60.91
Oct 25	64.55
Oct 25	60.11
Sep 25	9.57
Sep 25	8.63
Sep 25	8.21
Sep 25	8.12
Aug 25	8.43
Aug 25	8.26
Aug 25	8.85
Aug 25	10.28
Aug 25	10.5
Jul 25	10.43
Jul 25	10.69
Jul 25	10.52
Jul 25	10.59
Jun 25	10.61
Jun 25	10.87
Jun 25	10.9
Jun 25	11.66
May 25	11.7
May 25	12.31
May 25	12.39
May 25	12.61
May 25	13.24
Apr 25	12.04
Apr 25	12.98
Apr 25	12.55
Apr 25	15.1
Mar 25	13.15
Mar 25	12.55
Mar 25	12.43
Mar 25	11.97
Feb 25	13.74
Feb 25	15.39
Feb 25	16.83
Feb 25	15.3
Jan 25	15.15
Jan 25	15.26
Jan 25	13.66
Jan 25	13.41
Jan 25	13.08
Dec 24	26.07
Dec 24	25.44
Dec 24	21.98
Dec 24	22.41
Nov 24	20.01
Nov 24	19.34
Nov 24	19.86
Nov 24	20.5
Nov 24	19.93
Oct 24	21.71
Oct 24	21.85
Oct 24	22.28
Oct 24	23.59
Sep 24	16.46
Sep 24	16.52
Sep 24	16.94
Sep 24	18.62
Aug 24	18.44
Aug 24	17.42
Aug 24	16.66
Aug 24	14.27
Aug 24	14.42
Jul 24	14.39
Jul 24	15.53
Jul 24	14.62
Jul 24	14.44
Jun 24	43.35
Jun 24	55.13
Jun 24	47.37
Jun 24	48.74
May 24	47.24
May 24	46.19
May 24	49.54
Apr 24	47.73
Apr 24	50.81
Apr 24	53.26
Apr 24	53.79
Dec 23	98.06
Dec 23	101.39
Dec 23	91.89
Dec 23	74.5
Nov 23	73.77
Nov 23	83.01
Nov 23	63.96
Nov 23	70.23
Oct 23	77.73
Oct 23	80.42
Oct 23	79.1

Price to Book

MBXBF Price to Book by quarter
Period	Price to Book
Sep 26	1.66
Sep 26	1.65
Aug 26	1.66
Aug 26	1.64
Aug 26	1.68
Aug 26	1.69
Jul 26	1.7
Jul 26	1.7
Jul 26	1.63
Jul 26	1.67
Jul 26	1.69
Jun 26	1.56
Jun 26	1.62
Jun 26	1.37
Jun 26	1.36
May 26	1.37
May 26	1.31
May 26	1.19
May 26	1.27
May 26	1.29
Apr 26	1.25
Apr 26	1.2
Apr 26	1.22
Apr 26	1.19
Mar 26	1.2
Mar 26	1.25
Mar 26	1.29
Mar 26	1.16
Feb 26	1.18
Feb 26	1.08
Feb 26	1.08
Feb 26	1.08
Jan 26	1.08
Jan 26	1.16
Jan 26	1.26
Jan 26	1.25
Jan 26	1.21
Dec 25	1.08
Dec 25	1.05
Dec 25	1.19
Dec 25	1.09
Nov 25	1.18
Nov 25	1.16
Nov 25	1.22
Nov 25	1.19
Oct 25	1.21
Oct 25	1.19
Oct 25	1.25
Oct 25	1.32
Oct 25	1.23
Sep 25	1.21
Sep 25	1.09
Sep 25	1.04
Sep 25	1.03
Aug 25	1.07
Aug 25	1.05
Aug 25	1.12
Aug 25	1.3
Aug 25	1.33
Jul 25	1.32
Jul 25	1.35
Jul 25	1.33
Jul 25	1.34
Jun 25	1.4
Jun 25	1.43
Jun 25	1.43
Jun 25	1.53
May 25	1.54
May 25	1.62
May 25	1.63
May 25	1.66
May 25	1.74
Apr 25	1.58
Apr 25	1.71
Apr 25	1.65
Apr 25	1.99
Mar 25	2.02
Mar 25	1.93
Mar 25	1.91
Mar 25	1.84
Feb 25	2.11
Feb 25	2.36
Feb 25	2.59
Feb 25	2.35
Jan 25	2.33
Jan 25	2.35
Jan 25	2.1
Jan 25	2.06
Jan 25	2.01
Dec 24	1.98
Dec 24	1.93
Dec 24	1.67
Dec 24	1.7
Nov 24	1.52
Nov 24	1.47
Nov 24	1.51
Nov 24	1.55
Nov 24	1.51
Oct 24	1.65
Oct 24	1.66

No video analysis for this stock yet. Request one from our team.

News: MBXBF

accessnewswire.com · 9 Sep 2026

Microbix Qualifies as Supplier for Five Major Dx Test-Makers Product Lines for Support of Leading IVD Manufacturers

MISSISSAUGA, ON / ACCESS Newswire / September 9, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has completed formal qualification to become a supplier for five in-vitro diagnostics (IVD) manufacturers ("Dx Test-Makers"). Each of these five Dx Test-Makers are considered to be one of the ten largest such companies by revenues, and Microbix is pleased to have successfully completed their supplier audit & quality review processes.

seekingalpha.com · 13 Aug 2026

Microbix Biosystems Inc. (MBX:CA) Q3 2026 Earnings Call Transcript

accessnewswire.com · 13 Aug 2026

Microbix Reports Results for Q3 Fiscal 2026

Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, ON / ACCESS Newswire / August 13, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and nine months of fiscal 2026 ended June 30, 2026 ("Q3" and "YTD"). Results for Q3 and YTD continue to demonstrate the results of the Company's continuing work to rebuild revenues back to profitability following two client setbacks in mid-2025, with revenue growth of 17% in Q3 compared to Q3 fiscal 2025.

accessnewswire.com · 6 Aug 2026

Microbix Schedules Release of Results for Q3 Fiscal 2026

Results Release and Webinar Discussion on Morning of August 13, 2026 MISSISSAUGA, ON / ACCESS Newswire / August 6, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF), (Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its third quarter of fiscal 2026 ended June 30, 2026 ("Q3 2026") prior to the start of trading on August 13, 2026. At 10:00 AM ET that day, Microbix intends to hold a webinar discussion of Q3 2026 results with its CEO, CFO, and COO.